ENALARE THERAPEUTICS INC
PRINCETON, NEW JERSEY 085403013
$17.35M
Total Contract Value
6 awards
First Award
Sep 22, 2022
Last Award
Sep 5, 2024
Business Size
other than small
CAGE Code
8G2D2
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $11.40M | 5 |
Contract Awards
3 awards found
75A50122C00072
Department of Health and Human Services
$4.97M
Sep 5, 2024
THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE SUPPLEMENTAL FUNDING TO CLIN0001 TO SUPPORT THE DEVELOPMENT OF THE AGNOSTIC RESPIRATORY STIMULANT ENA-001, UPDATE SECTIONS F.2 DELIVERABLES, G.1. CONTRACTING OFFICER, G.4 FINANCIAL REPORT, AND ATTACHMENT
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75A50122C00072
Department of Health and Human Services
$469K
Sep 20, 2023
PROVIDE SUPPLEMENTAL FUNDING FOR ENA-001
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75A50122C00072
Department of Health and Human Services
$5.96M
Sep 22, 2022
ENALARE THERAPEUTICS: AN AGNOSTIC RESPIRATORY STIMULANT FOR USE AS A MEDICAL COUNTERMEASURE TO TREAT RESPIRATORY DEPRESSION
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022
Business Details
- UEI
- MDJFW877BCV6
- CAGE Code
- 8G2D2
- Address
- 161 HODGE RD
PRINCETON, NJ 085403013 - Congressional District
- NJ-12
- Phone
- 6094628886
Parent Company
ENALARE THERAPEUTICS INC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov